| Application no. and date | 12179389.7 (espacenet) (Federated) (European Patent Register), 20090624 | | Patent/reg. no. and date | DK/EP 2537862, 20150318 | | Publication date | 20121226 | | Priority no. and date | US 129402 P, 20080624, EP 08158893, 20080624 | | EP pub. no. and date |
EP 2537862 20121226 | | Effective date | | | Applicant/owner | Octapharma AG, Seidenstrasse 2
8853 Lachen, CH | | Applicant ref. no. | P56131DK01 | | Inventor | Winge, Stefan, Nordenflychtsvägen 55
112 75 Stockholm, SE,
Ericsson, Ulrika, Svandammsvägen 42
126 35 Hägersten, SE,
Jernberg, Mats, Atlasvägen 31
131 34 Nacka, SE,
Borgvall, Carin, LövÃ¥svägen 9
191 45 Sollentuna, SE,
Gilljam, Gustav, Gryningsvägen 12
142 42 SkogÃ¥s, SE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07K 14/755 (2006.01) | | Title | En fremgangsmåde til at oprense koagulationsfaktor VIII | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
